ACT vs PSA · P/E 9.3, rev $1.20B vs rev $4.82B
Enact Holdings Inc (ACT) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Enact Holdings Inc (ACT) is a insurance - specialty company listed on NASDAQ.
PSA (PSA) common stock.
Latest reported ACT revenue for 2024-12-31 was $1.20B. Revenue was up 4.2% from 2023-12-31 to 2024-12-31. ACT currently screens at market cap $5.99B and trailing P/E 9.3.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
ACT currently screens at market cap $5.99B and trailing P/E 9.3. PSA currently screens at market cap $0.
Not investment advice. Open the ACT and PSA stock pages for the full models.
Not investment advice.